变向性
医学
心力衰竭
重症监护医学
语句(逻辑)
心脏病学
临床心脏病学
内科学
协商一致会议
政治学
法学
作者
Finn Gustafsson,Kevin Damman,Sanem Nalbantgil,Linda W. van Laake,Laurens F. Tops,Thomas Thum,Stamatis Adamopoulos,Michael J. Bonios,Andrew J.S. Coats,María G. Crespo‐Leiro,Mandeep R. Mehra,Gerasimos Filippatos,Loreena Hill,Marco Metra,Ewa A. Jankowska,Nicolaas de Jonge,David M. Kaye,M. Masetti,John Parissis,Davor Miličić,Petar Seferović,Giuseppe Rosano,Tuvia Ben Gal
摘要
This clinical consensus statement reviews the use of inotropic support in patients with advanced heart failure. The current guidelines only support use of inotropes in the setting of acute decompensated heart failure with evidence of organ malperfusion or shock. However, inotropic support may be reasonable in other patients with advanced heart failure without acute severe decompensation. The clinical evidence supporting use of inotropes in these situations is reviewed. Particularly, patients with persistent congestion, systemic hypoperfusion, or advanced heart failure with need for palliation, and specific situations relevant to implantation of left ventricular assist devices or heart transplantation are discussed. Traditional and novel drugs with inotropic effects are discussed and use of guideline‐directed therapy during inotropic support is reviewed. Finally, home inotropic therapy is described, and palliative care and end‐of‐life aspects are reviewed in relation to management of ongoing inotropic support (including guidance for maintenance and weaning of chronic inotropic therapy support).
科研通智能强力驱动
Strongly Powered by AbleSci AI